Searched over 200M research papers
7 papers analyzed
These studies suggest that being anemic can make you tired.
5 papers analyzed
20 papers analyzed
Anemia is a prevalent condition among the elderly and is often mistakenly accepted as a normal part of aging. However, research indicates that anemia in older adults is associated with significant fatigue and weakness, which can limit daily activities and increase cardiovascular risks. Studies have shown that anemia is a correctable condition in the elderly, and treating it can alleviate fatigue and improve quality of life.
Cancer patients frequently experience anemia, which is strongly linked to fatigue and reduced health-related quality of life (HRQOL). Multiple studies have demonstrated that improvements in hemoglobin levels are associated with significant reductions in fatigue and enhancements in physical, functional, and emotional well-being . For instance, in a study involving anemic cancer patients, those who responded to hemoglobin treatment reported substantial improvements in energy, ability to perform daily activities, and overall health.
Patients with chronic kidney disease (CKD) on dialysis often suffer from anemia, which is closely associated with fatigue. Research has shown that anemia in CKD patients leads to decreased energy, tiredness, shortness of breath, and loss of strength. Treatment with erythropoiesis-stimulating agents (ESAs) has been found to significantly reduce fatigue in these patients, particularly when hemoglobin levels are increased from below 10 g/dL to above this threshold.
The use of ESAs, such as epoetin alfa and darbepoetin alfa, has been shown to effectively alleviate fatigue in anemic patients across various conditions, including cancer and CKD. Studies have reported that increasing hemoglobin levels through ESA therapy leads to meaningful improvements in fatigue and overall quality of life . For example, elderly patients with chronic anemia who received epoetin alfa treatment experienced significant increases in hemoglobin levels, which corresponded with reduced fatigue and enhanced ability to perform daily activities.
Qualitative analyses of patient-reported symptoms have highlighted that anemia is commonly associated with decreased energy, tiredness, shortness of breath, and weakness. These symptoms significantly impact patients' daily lives and overall well-being. Instruments like the Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale have been developed to measure the impact of anemia-related fatigue on quality of life, demonstrating that higher hemoglobin levels are associated with less fatigue and better physical and functional well-being.
In summary, anemia is a significant contributor to fatigue across various populations, including the elderly, cancer patients, and those with chronic kidney disease. Treating anemia and improving hemoglobin levels can lead to substantial reductions in fatigue and improvements in quality of life. Therefore, addressing anemia should be a priority in managing fatigue and enhancing the overall well-being of affected individuals.
Most relevant research papers on this topic